We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
Parexel acquires The Medical Affairs Company to leverage SMLs and expand in international markets
The Medical Affairs Company (TMAC), a full-service CRO for the medical device and pharmaceutical industries, has recently been acquired by Parexel, a worldwide biopharmaceutical clinical trials company. Parexel intends to utilize many of the current services offered by TMAC, including medical science liaisons (MSLs) and clinical nurse educators.
A cautiously optimistic healthcare M&A outlook for 2017
Although 2016 was a lackluster year for megadeals in healthcare, a recent flurry of big deals has Wall Street investors cautiously optimistic that 2017 will bring new mergers and big-ticket acquisitions. An increasingly competitive landscape in healthcare, coupled with signs that the new U.S. presidential administration may usher in more business-friendly policies, could spur major deals in the upcoming year.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.
